Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Austrian firm is the latest European company to turn to equity markets due to high cost of borrowing -
First market sale by government fund sets for up more disposals next year
-
Alstom conceded defeat to the stockmarket this week and confirmed it may need a rights issue
-
The books are covered at the final guidance of €5.30 a share, say sources
-
The Swedish landlord has begun a highly dilutive rights issue to repay debt
-
Shares in the French rolling stock manufacturer plummeted last month after a profit warning
